These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 3558984)

  • 61. [Effect of sulmazol on left ventricular function in congestive cardiomyopathy].
    Maurer E; Klein W; Brandt D
    Arzneimittelforschung; 1983; 33(5):760-3. PubMed ID: 6683555
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Isosorbide dinitrate for the relief of severe heart failure after myocardial infarction.
    Mantle JA; Russell RO; Moraski RE; Rackley CE
    Am J Cardiol; 1976 Feb; 37(2):263-8. PubMed ID: 1108634
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Comparative hemodynamic effects of intravenous dobutamine and MDL-17,043, a new cardioactive drug, in severe congestive heart failure.
    Amin DK; Shah PK; Shellock FG; Hulse S; Brandon G; Spangenberg R; Swan HJ
    Am Heart J; 1985 Jan; 109(1):91-8. PubMed ID: 3155585
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Comparison of the acute hemodynamic effects of ibopamine and dopamine in chronic congestive heart failure.
    Sannia L; Ibba GV; Castellaccio M; Dore L
    Arzneimittelforschung; 1986 Feb; 36(2A):355-9. PubMed ID: 3707649
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Spectrum of acute hemodynamic effects of nifedipine in severe congestive heart failure.
    Elkayam U; Weber L; McKay C; Rahimtoola S
    Am J Cardiol; 1985 Sep; 56(8):560-6. PubMed ID: 4036843
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Effect of isosorbide dinitrate on cardiac output in severe cardiac failure: relation to initial hemodynamics, ventricular volume, and the preload reserve mechanism.
    Lewis BS; Hardoff R; Halon DA
    Clin Cardiol; 1989 Sep; 12(9):514-20. PubMed ID: 2791373
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Hemodynamic advantage of combined administration of oral ibopamine and nitroprusside in patients with ischemic and idiopathic congestive cardiomyopathy.
    Dei Cas L; Fappani A; Riva S; Metra M; Cicogna R; Manca C; Visioli O
    Clin Cardiol; 1985 Aug; 8(8):427-32. PubMed ID: 4028536
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Hemodynamic effects of intravenous prenalterol in patients on long-term digoxin therapy for congestive heart failure.
    Dahlström U; Karlsson E; Wranne B
    Eur Heart J; 1982 Aug; 3(4):331-8. PubMed ID: 7128622
    [No Abstract]   [Full Text] [Related]  

  • 69. [Sulmazole: a new positive inotropic agent].
    Renard M; Jacobs P; Melot C; Dresse A; Bernard R
    Ann Cardiol Angeiol (Paris); 1984; 33(4):219-22. PubMed ID: 6465815
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Flosequinan: a vasodilator with positive inotropic activity.
    Corin WJ; Monrad ES; Strom JA; Giustino S; Sonnenblick ES; LeJemtel T
    Am Heart J; 1991 Feb; 121(2 Pt 1):537-40. PubMed ID: 1990760
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Pirbuterol: a new oral sympathomimetic amine for the treatment of congestive heart failure.
    Sharma B; Hoback J; Francis GS; Hodges M; Asinger RW; Cohn JN; Taylor CR
    Am Heart J; 1981 Sep; 102(3 Pt 2):533-41. PubMed ID: 6115572
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Intravenous amrinone in left ventricular failure complicated by acute myocardial infarction.
    Taylor SH; Verma SP; Hussain M; Reynolds G; Jackson NC; Hafizullah M; Richmond A; Silke B
    Am J Cardiol; 1985 Jul; 56(3):29B-32B. PubMed ID: 4025156
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Development of pharmacodynamic tolerance to prozosin in congestive heart failure.
    Desch CE; Magorien RD; Triffon DW; Blanford MF; Unverferth DV; Leier CV
    Am J Cardiol; 1979 Nov; 44(6):1178-82. PubMed ID: 495512
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Hemodynamic action of nicorandil in chronic congestive heart failure.
    Solal AC; Jaeger P; Bouthier J; Juliard JM; Dahan M; Gourgon R
    Am J Cardiol; 1989 Jun; 63(21):44J-48J. PubMed ID: 2525325
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Comparative effects on hemodynamics of enoximone (MDL 17,043), dobutamine and nitroprusside in severe congestive heart failure.
    Installé E; Gonzalez M; Jacquemart JL; Collard P; Roulette F; Pourbaix S; Tremouroux J
    Am J Cardiol; 1987 Aug; 60(5):46C-52C. PubMed ID: 2956868
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Acute haemodynamic effects of ibopamine in patients with severe congestive heart failure.
    Ghirardi P; Brusoni B; Mangiavacchi M; Bianco L; Col J; Metra M; Dei Cas L
    Br J Clin Pharmacol; 1985 May; 19(5):613-8. PubMed ID: 4005102
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Separation of the direct myocardial and vasodilator actions of milrinone administered by an intracoronary infusion technique.
    Ludmer PL; Wright RF; Arnold JM; Ganz P; Braunwald E; Colucci WS
    Circulation; 1986 Jan; 73(1):130-7. PubMed ID: 3940664
    [TBL] [Abstract][Full Text] [Related]  

  • 78. The acute hemodynamic effects of a new agent, MDL 17,043, in the treatment of congestive heart failure.
    Uretsky BF; Generalovich T; Reddy PS; Spangenberg RB; Follansbee WP
    Circulation; 1983 Apr; 67(4):823-8. PubMed ID: 6218939
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Dose dependence of chronic positive inotropic effect of vesnarinone in patients with congestive heart failure due to idiopathic or ischemic cardiomyopathy.
    Kass DA; Van Anden E; Becker LC; Kasper EK; White WB; Feldman AM
    Am J Cardiol; 1996 Sep; 78(6):652-6. PubMed ID: 8831399
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Positive inotropic therapy for short-term support and long-term management of patients with congestive heart failure: hemodynamic effects and clinical efficacy of MDL 17,043.
    Uretsky BF; Valdes AM; Reddy PS
    Circulation; 1986 Mar; 73(3 Pt 2):III219-29. PubMed ID: 2935328
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.